#SpeeDr00t@Black Falcon<br>#bid20752<p><b><span style="font-size: 18pt;">MAXdev MD-Pro User.PHP Cross-Site Scripting Vulnerability</span></b></p><br><br><a href="http://www.securityfocus.com/bid/20752/info">info</a><br><a href="http://www.securityfocus.com/bid/20752/discuss">discussion</a><br><a href="http://www.securityfocus.com/bid/20752/exploit">exploit</a><br><a href="http://www.securityfocus.com/bid/20752/solution">solution</a><br><a href="http://www.securityfocus.com/bid/20752/references">references</a><br><br><br><br><br>#<br>#<div id="vulnerability">
<span class="title"></span><br/><br/>
<table border="0" cellpadding="4" cellspacing="0">
<tr>
<td>
<span class="label">Bugtraq ID:</span>
</td>
<td>
				20752
			</td>
</tr>
<tr>
<td>
<span class="label">Class:</span>
</td>
<td>
				Input Validation Error
			</td>
</tr>
<tr valign="top">
<td>
<span class="label">CVE:</span>
</td>
<td>
</td>
</tr>
<tr>
<td>
<span class="label">Remote:</span>
</td>
<td>
				Yes
			</td>
</tr>
<tr>
<td>
<span class="label">Local:</span>
</td>
<td>
				No
			</td>
</tr>
<tr>
<td>
<span class="label">Published:</span>
</td>
<td>
				Oct 26 2006 12:00AM
			</td>
</tr>
<tr>
<td>
<span class="label">Updated:</span>
</td>
<td>
				Oct 27 2006 12:33AM
			</td>
</tr>
<tr>
<td>
<span class="label">Credit:</span>
</td>
<td>
				R00TATI is credited with the discovery of this vulnerability.
			</td>
</tr>
<tr valign="top">
<td>
<span class="label">Vulnerable:</span>
</td>
<td>
				
					MAXdev MD-Pro 1.0.76 <br/>
</td>
</tr>
<tr>
<td colspan="2">
<div class="breakline"></div>
</td>
</tr>
<tr valign="top">
<td>
<span class="label">Not Vulnerable:</span>
</td>
<td>
</td>
</tr>
</table>
</div><br><br>#<br>##no_exploit_link<br><br><br><br>#<br>#<div id="vulnerability">
<span class="title"></span><br/><br/>
	Attackers can exploit this issue by enticing a victim user into following a malicious URI.<br/><br/>An example URI has been provided:<br/><br/> http://www.example.com/user.php?uname=1&amp;module=NS-LostPassword&amp;op=code
	
		<ul>
</ul>
</div>